2022

2022

News

Publication of a Paper on the Improvement of Glucose Tolerance in Mitochondrial Diabetes by 5-Aminolevulinic Acid (5-ALA)
December 9, 2022
News

Launch of “WIZALA (WithALA),” a Supplement for Puppies and Kittens
October 13, 2022
Information

Announcement of Anti-Doping Certification for 5-Aminolevulinic Acid (5-ALA) Raw Materials
September 9, 2022
News

Announcement of Anti-Doping Certification for 5-Aminolevulinic Acid (5-ALA) Raw Materials
August 30, 2022
News

Asahara Brewery Co., Ltd. Launches 5-ALA-Containing Alcoholic Beverage
June 27, 2022
Information

Filing of a Patent Infringement Lawsuit Against Toa Industry Co., Ltd.
April 25, 2022
News

Publication of a Paper on 5-Aminolevulinic Acid (5-ALA) Against the Omicron Variant of COVID-19
April 12, 2022
News

Patent Acquisition for 5-Aminolevulinic Acid (5-ALA) in the Treatment of COVID-19
April 8, 2022
News

Publication of a Paper on the Improvement Trend of Post-COVID-19 Sequelae by Continuous Intake of 5-Aminolevulinic Acid (5-ALA)
March 29, 2022
News

Publication of a Paper on the Infection Inhibition of Various Mutant Strains of the COVID-19 Virus by 5-Aminolevulinic Acid (5-ALA)
January 11, 2022

KIYAN PHARMA Co., Ltd.

Contact Information

6-2-6 Kojimachi, Chiyoda-ku, Tokyo 102-0083, PMO Kojimachi 8th floor

Mail：info@kiyan.jp

Contact UsContact Us